Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
16.05    0.00 (0.00%)
Bid:
16.05
Ask:
16.50
Spread: 0.45 (2.804%)
Market Cap: £20.30m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Board Appointment

10 Jun 2025 07:00

RNS Number : 0882M
Cirata PLC
10 June 2025
 

10 June 2025

 

Cirata plc

("Cirata" or the "Company")

Board Appointment

 

 

Cirata (LSE: CRTA), is pleased to announce that Sarah Rolls has been appointed as a NonExecutive Director with immediate effect.

 

Sarah has previously served as Group Financial Controller of Sage Group (FTSE 100) and Tate & Lyle (FTSE 250). She is also a trusted Board advisor and business partner, who benefits from 5 years of Big-4 partnership experience. Sarah is experienced across a diverse range of sectors including consumer goods, retail, services and technology, with expertise in financing and tax strategy, risk, financial reporting and controls, M&A and delivering transformational change.

 

Sarah has also been appointed as Chair of the Audit and Risk Committee of Cirata with immediate effect.

 

Ken Lever, Chair of Cirata, commented:

"Sarah brings a wealth of commercial experience across a range of sectors to our Board. As the former Group Controller of a FTSE 100 company, in addition to a FTSE 250 business, and as a partner at KPMG she has a depth of leadership experience across finance, risk management and governance, which will be of significant benefit to the Cirata Board and the ongoing development of the Company. We are delighted that Sarah has decided to join us."

 

Regulatory disclosure The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

Sarah Jane Rolls, aged 50, holds no ordinary shares or options in the Company. Sarah's current and previous directorships are as follows: 

Current Directorships/Partnerships

Previous Directorships/Partnerships (last 5 years)

Dry Hill Park Limited

Tonbridge Grammar School

Tate & Lyle Export Holdings Limited

Tate & Lyle Group Services Limited

Tate & Lyle Holdings Americas Limited

Tate & Lyle Holdings Limited

Tate & Lyle Industries Limited

Tate & Lyle International Finance PLC

Tate & Lyle Investments America Limited

Tate & Lyle Investments Brazil Limited

Tate & Lyle Investments Limited

Tate & Lyle Technology Limited

Tate & Lyle UK Limited

ACCPAC UK Limited

HR Bakery Ltd

Interact UK Holdings Limited

KCS Global Holdings Limited

Multisoft Financial Systems Limited

Protx Group Limited

Protx Limited

Sage (UK) Ltd

Sage CRM Solutions Limited

Sage Euro Hedgeco 1

Sage Euro Hedgeco 2

Sage Far East Investments Limited

Sage Global Services Limited

Sage Hibernia Investments No. 1 Limited

Sage Hibernia Investments No. 2 Limited

Sage Holding Company Limited

Sage Holdings Limited

Sage Intacct UK Limited

Sage Irish Investments LLP

Sage Irish Investments One Limited

Sage Irish Investments Two Limited

Sage Management Limited

Sage Online Holdings Limited

Sage Overseas Limited

Sage People Limited

Sage Software Ltd

Sage Treasury Company Limited

Sage USD Hedgeco 1

Sage USD Hedgeco 2

Sage Whitley Limited

Sagesoft

Snowdrop Systems Limited

TAS Software Limited

Sage Irish Finance Company Unlimited Company

Sage Treasury Ireland Unlimited Company

Tate & Lyle Ventures Limited

 

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

 

 

For further information, please contact: 

 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer

Ricardo Moura, Chief Financial Officer (Interim)

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Brough Ransom / Ben Good

Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / John More

 

 

About Cirata

 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGGVNLGGKZM
Date   Source Headline
30th Sep 20247:00 amRNSHCSC Contract Renewal
25th Sep 20247:00 amRNSAppointment of Interim CFO
19th Sep 202410:30 amRNSHolding(s) in Company
19th Sep 202410:30 amRNSHolding(s) in Company
4th Sep 20247:00 amRNSInterim results
31st Jul 20245:44 pmRNSHolding(s) in Company
31st Jul 20242:35 pmRNSDirector/PDMR Shareholding
26th Jul 20241:51 pmRNSHolding(s) in Company
19th Jul 20245:54 pmRNSDelay of Admission
17th Jul 20247:00 amRNSResult of Fundraising
16th Jul 20244:47 pmRNSPrimaryBid Offer
16th Jul 20244:46 pmRNSLaunch of Fundraise
16th Jul 20244:45 pmRNSQ2 Trading Update and Outlook
28th Jun 20248:00 amRNSBlock Listing Return
25th Jun 20247:08 amRNSGM Launches Phase 2
19th Jun 20247:00 amRNSTotal Voting Rights
21st May 20247:00 amRNSOPPO Contract Renewal
14th May 20243:28 pmRNSResult of Annual General Meeting
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.